ADA Scientific Sessions 2026 Abstract

Real-World Trajectories of Type 2 Diabetes Pharmacotherapy in the United States: A Nationwide Clustering Analysis of Electronic Health Records

By Polina Kukhareva

Study in peoplePopulations

The paper

Polina Kukhareva

Salt Lake City

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 2317-P

doi.org/10.2337/db26-2317-p

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression